sgb 1534 has been researched along with phenylephrine in 5 studies
| Studies (sgb 1534) | Trials (sgb 1534) | Recent Studies (post-2010) (sgb 1534) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 13,797 | 857 | 2,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akima, M; Imagawa, J; Sakai, K | 1 |
| Sugimoto, T; Uchida, Y | 1 |
| Imagawa, J; Nabata, H; Sakai, K | 1 |
| Aono, J; Sakai, K | 1 |
| Ishikawa, S | 1 |
5 other study(ies) available for sgb 1534 and phenylephrine
| Article | Year |
|---|---|
In vivo experiments for the evaluation of alpha 1-adrenoceptor antagonistic effects of SGB-1534 on canine urethra.
Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Female; Hypogastric Plexus; Phenylephrine; Prazosin; Quinazolines; Urethra | 1989 |
[Cardiovascular effect of a novel substance, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl] ethyl]-2,4 (1H, 3H)-quinazolinedione monohydrochloride (SGB 1534)].
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Dogs; Heart Rate; Myocardial Contraction; Phenylephrine; Quinazolines; Vascular Resistance | 1985 |
Comparison of cardiovascular effects of SGB-1534 and prazosin, selective alpha 1-adrenoceptor antagonists, in anesthetized dogs.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hemodynamics; Male; Phenylephrine; Prazosin; Quinazolines; Renal Circulation; Vascular Resistance; Vasoconstriction | 1987 |
Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Clonidine; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Phenylephrine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1988 |
Effects of a new alpha 1-adrenoceptor blocking agent, 3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-(1H,3H)-quinazoline-2, 4-dione monohydrochloride (SGB1534), on electrical and mechanical properties of guinea-pig mesenteric artery.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Electric Stimulation; Female; Guinea Pigs; Histamine; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Quinazolines; Serotonin; Synaptic Transmission | 1984 |